China's Cross-Border E-Commerce Crackdown: What Food and Supplement Brands Need to Know in 2026

Summary

• A series of 2026 regulatory updates has ended the "lighter-touch" compliance era for China's cross-border e-commerce (CBEC) channel. International food and supplement brands now face scrutiny on par with domestic companies, with legal liability extending to platforms and agencies.

• Live-streaming now accounts for over 23% of China's CNY 5 trillion online retail market and is regulated as a distinct legal category. New rules impose direct obligations on streamers and agencies, requiring brands to formally review all on-stream claims before going live.

• The most urgent change requires all CBEC food brands to appoint a registered domestic entity in China responsible for product recalls. This is a non-negotiable prerequisite for continued market access, enforced by platforms like Tmall Global and Douyin.

• Managing this heightened complexity requires a proactive approach. Brands can use platforms like Taama to assess ingredient permissibility and marketing claims against China's specific regulations before products are listed, preventing platform flags and enforcement actions.

If you're selling food or supplements into China via cross-border e-commerce (CBEC) — or planning to — 2026 has delivered an unusually dense cluster of regulatory change. Three major updates have been issued in quick succession, covering e-commerce platform liability, false claims enforcement, live-streaming commerce, and product recall obligations. Taken individually, each would warrant attention. Taken together, they signal something more significant: the CBEC channel, long regarded as a lighter-touch alternative to full domestic market entry, is now subject to a level of regulatory scrutiny that closely mirrors what domestic brands face.

This isn't cause for alarm. China remains one of the most commercially significant markets in the world for international food and supplement brands, and the CBEC channel remains open. But the compliance calculus has changed. Brands that have relied on regulatory ambiguity — through informal claims, unreviewed KOL content, or operating without a Chinese domestic entity — will find that ambiguity is rapidly being eliminated. What follows is a clear-eyed breakdown of what changed, what it means in practice, and what your team should be doing now.

Section 1: The E-Commerce Law Overhaul (July 2026)

In July 2026, China's State Administration for Market Regulation (SAMR) and the Ministry of Commerce (MOFCOM) released a significant draft amendment to China's E-Commerce Law for public comment, with the comment period closing on August 4, 2026. This is a foundational legal development — not a sector-specific rule, but a structural shift in how China asserts authority over cross-border digital commerce.

What the draft introduces:

• Extra-territorial jurisdiction. The draft formally extends China's regulatory reach to overseas e-commerce activities that disrupt the domestic market or cause harm to Chinese consumers. This closes a long-standing jurisdictional gap that international brands have, in practice, operated within.

• Joint platform liability. Platforms such as Tmall Global, JD Worldwide, and Douyin/TikTok Shop can now be held jointly liable with merchants if they outsource verification or operational responsibilities — such as product listing reviews or store setup — to third parties, and consumer harm results. Platforms have a strong financial incentive to ensure the merchants they host are compliant.

• Expanded enforcement tools. Authorities are no longer restricted to financial penalties. The new framework includes the ability to impose registration holds, request licence revocations from relevant authorities, and order business suspensions for non-compliant entities. The enforcement toolkit is materially broader than before.

• "Unreliable entity list." The draft introduces a formal mechanism for retaliatory measures against foreign entities deemed to have discriminated against or harmed Chinese e-commerce interests — a provision that reflects the broader geopolitical context in which these regulatory changes are occurring.

What this means for your brand in practice:

Most international brands will never interact directly with SAMR. The pressure from this law will be felt through the platforms. To avoid their own liability exposure, Tmall Global, JD Worldwide, and Douyin will tighten their merchant-facing requirements — more rigorous product listing reviews, more frequent documentation requests (certificates of analysis, certificates of origin, safety substantiation), and faster action on non-compliant product pages. Brands that are well-prepared with documentation and clean listings will move through these processes. Those that aren't will face delays, delistings, and potential account-level consequences.

Section 2: The False Claims Crackdown (April 2026)

In April 2026, SAMR launched a six-month nationwide enforcement campaign targeting false and misleading promotion in online food and health food sales. Critically, the scope of this campaign explicitly includes cross-border retail import foods — this is not a domestic brand issue that international sellers can observe from a distance.

The full marketing chain is in scope. The campaign holds accountable everyone involved in bringing a product claim to a Chinese consumer: brand owners, platforms, sellers, live-streamers, marketing agencies, and advertisers. There is no off-ramp for overseas brands on the grounds that the content was produced outside China.

SAMR's specific areas of focus include:

• Ordinary foods promoted — explicitly or implicitly — with claims related to disease treatment, prevention, or health functions. The line between "wellness" language and a functional health claim is tightly drawn under Chinese regulation, and what reads as aspirational marketing copy in a European or North American context may constitute an illegal claim in China.

• Registered "blue hat" health foods promoted with exaggerated language or disease-treatment implications beyond what is permitted in their registration dossier.

• Advertising that misrepresents a product's geographic origin, ingredient composition, testing outcomes, certifications held, or the standards it adheres to.

• A specific focus on "internet-famous" (网红) viral products — a category that, by definition, includes many of the international supplement and functional food brands that have grown rapidly on Douyin and Xiaohongshu through KOL-driven campaigns.

Platform consequences are severe. Platforms found to be hosting misleading promotional content face penalties in the multi-billion yuan range, along with suspensions of 3–9 months on their ability to onboard new merchants. This creates enormous pressure on platforms to police their merchant base proactively.

What this means for your brand in practice:

Every product listing, banner, social caption, and KOL brief targeting Chinese consumers needs to be reviewed against the claims that are actually permitted for that product under Chinese regulation. The key variable is your product's Chinese regulatory classification. China's health food regulatory framework distinguishes sharply between ordinary foods, filing-track health foods (such as vitamins and minerals), and registration-track "blue hat" health foods. A structure-function claim that is entirely permissible under FDA or TGA frameworks may be an illegal disease-prevention claim for an ordinary food in China. Misclassification — or assuming that a claim acceptable elsewhere is acceptable in China — is the root cause of most downstream enforcement issues.

Section 3: Live-Streaming Commerce Regulation (Effective March 2026)

Effective March 20, 2026, China became the first government in the world to regulate food live-streaming as a distinct legal category. For brands that view live-streaming as a supplementary channel, this framing needs updating. Live-streaming now accounts for over 23% of China's total online retail sales, a market valued at more than CNY 5 trillion (approximately USD 675 billion). For food and supplement brands on Douyin in particular, live-streaming is often the primary commercial driver — not a secondary activation layer.

Who carries legal obligations under the new rules:

The regulations impose direct and distinct obligations on four parties:

1. Platform operators (Douyin, Xiaohongshu, Taobao Live)

2. Live-streaming room operators (typically the brand's store or its agency partner)

3. Streamers and hosts (KOLs and in-house presenters)

4. MCN agencies managing the streamer relationships

This is a full-chain liability model, consistent with the approach taken in the false claims campaign. There is no single party that can be isolated as the only responsible actor.

The key requirements under the new rules include:

• Platform obligations: Platforms must establish formal service agreements with sellers operating live-streaming rooms. They must create and maintain a Food Safety Risk Control List tailored to different product categories, and must verify — and re-verify every six months — the identity and licensing information of streamers operating on their platforms.

• Streamer conduct restrictions: Streamers are prohibited from using filters, adjusted lighting, or any technology that alters the apparent colour, texture, or sensory characteristics of food products in a misleading way. No medical terminology or claims implying disease prevention or treatment are permitted unless the product in question holds a registered "blue hat" health food approval. AI-generated avatars or virtual hosts must be clearly and explicitly disclosed to the audience — there is no ambiguity permitted here.

• Mandatory training: Before conducting their first live session, streamers must complete formal training covering consumer rights, product safety, and online transaction law. Annual renewal is required. This is a verifiable credential, not a self-certification.

What this means for your brand in practice:

If your China go-to-market strategy involves KOL partnerships, MCN agencies, or Douyin campaigns — and for most brands targeting younger Chinese consumers, it does — then your partners' compliance is now a direct risk factor for your brand. A streamer making an unauthorised health claim about your supplement, even off-script or in a casual moment during a live session, can expose your brand to enforcement action under the full-chain liability framework.

The response to this is operational, not just contractual. Vet your MCN partners and confirm their streamers have completed mandatory training. Build a formal content review process into your campaign workflow — every script, every talking point, every claim that will be made on-stream about your product should be reviewed against your product's permitted Chinese regulatory classification before the session goes live. Your agency contracts should explicitly prohibit non-compliant claims and include clear liability provisions for breaches.

Section 4: The Recall Gap Closes (February 2026)

The fourth and arguably most structurally significant change arrived earliest in the year. Effective February 2026, SAMR and MOFCOM jointly issued new recall regulations specifically for CBEC imported foods.

The core requirement: Every overseas CBEC food enterprise selling into China must now appoint a domestic entity, registered in mainland China, that is formally responsible for managing and executing product recalls. This closes a critical operational gap that has existed since CBEC became a mainstream market entry route. Previously, overseas brands without a domestic presence had no clear, legally accountable mechanism for handling product safety events. That gap is now closed by regulation.

Platform enforcement obligations: E-commerce platforms are required to supervise sellers' compliance with these recall requirements. They have both the authority and the obligation to suspend the operations of enterprises that have not appointed a compliant domestic recall entity.

Penalties: Failure to meet recall obligations exposes all parties — the overseas brand, the domestic entity, and the platform — to financial penalties and to negative entries on China's corporate social credit system. The social credit implications carry downstream consequences that extend beyond the immediate enforcement event, affecting future regulatory approvals, platform relationships, and import clearances.

What this means for your brand in practice:

This is not a documentation upgrade or a best-practice recommendation. It is a non-negotiable structural requirement for selling food or supplements via CBEC into China. Brands that have historically operated through a Tmall Partner (TP) without a separate registered domestic entity need to assess whether that TP is equipped and willing to serve as the formal recall entity — and to get that confirmation in writing. If not, appointing an appropriate domestic entity is now a prerequisite for continued market access, not a future consideration.

What Brands Should Do Now: A 7-Point Compliance Checklist

The following actions are presented in order of structural priority. Some are time-sensitive; all are necessary.

1. Audit all China-facing marketing assets. Systematically review every product listing, store banner, social media post, and KOL content brief on Chinese platforms. Remove or revise any claim that goes beyond what is demonstrably permitted for your product's current Chinese regulatory classification. Do not assume that compliant language from other markets transfers.

2. Appoint and formally confirm your domestic recall entity. If you do not have a registered entity in mainland China with formal, documented responsibility for managing product recalls, this is your most urgent structural action item. Confirm the appointment in a legally binding agreement, not just an informal arrangement with your TP or local partner.

3. Verify your product's Chinese regulatory classification. This single step prevents most downstream compliance issues. Work with your domestic partner or a specialist consultant to confirm whether each of your products is classified as an ordinary food, a filing-track health food (e.g., standard vitamin and mineral supplements), or a registration-track health food requiring a "blue hat" approval. The claims universe for each classification is entirely different. SAMR, the National Health Commission (NHC), and GACC are the relevant authorities.

4. Vet your MCN and KOL partners. Update your agreements to require compliance with the March 2026 live-streaming regulations. Request proof that streamers have completed mandatory training. Implement a formal content review step for all live-stream scripts and talking-point briefs, and ensure your contracts include liability provisions for compliance breaches by the streamer or agency.

5. Disclose AI-generated and virtual host content. If you use AI-generated avatars, synthetic voices, or virtual hosts in any live-streaming environment, explicit and clear disclosure to the audience is now legally required. Review all active and planned campaigns and confirm this requirement is met.

6. Factor in pre-clearance time for products with novel or non-standard ingredients. As platforms become more risk-averse in response to their new liability exposure, internal review timelines for products with unusual or less familiar ingredients are lengthening. If you are planning a new product launch on Chinese platforms, build additional lead time into your timeline and have your ingredient documentation ready before, not during, the listing process. For context on overseas manufacturer registration requirements that may apply, GACC Decree No. 248 remains the relevant framework.

7. Consider multi-market compliance tools if you're managing APAC at scale. For brand and regulatory teams managing China alongside multiple other APAC markets, the manual burden of tracking ingredient permissibility and claims rules across jurisdictions is substantial. Platforms like Taama assess ingredient permissibility and claims compliance across China and 17 other markets simultaneously — allowing teams to confirm what's actually permissible before a product is listed, rather than responding to a platform flag after the fact.

The New Baseline for CBEC

China is not pulling back from cross-border e-commerce as a trade channel. The infrastructure, the consumer appetite, and the commercial opportunity remain. What is ending is the implicit discount that CBEC has historically received relative to domestic market entry — the lighter documentation burden, the softer claims scrutiny, the absence of mandatory domestic infrastructure requirements.

The 2026 regulatory package, taken as a whole, signals that selling food and supplements into China via CBEC now requires the same level of compliance rigour as entering the domestic market through a traditional import route. That is a meaningful shift, but it is also a manageable one for brands that treat compliance as a commercial prerequisite rather than an after-the-fact filter.

Brands that audit their claims now, appoint domestic recall entities, and build compliance into their KOL and live-streaming workflows will be positioned for sustainable growth in one of the world's most commercially significant markets. Those that don't will find that platforms — operating under their own escalating liability exposure — are increasingly unwilling to carry the risk of non-compliant products on their behalf.

The window to get ahead of this is open. It won't stay that way indefinitely.

Frequently Asked Questions

What is the most urgent regulatory change for international food and supplement brands selling into China?

The most urgent change is the mandatory appointment of a registered domestic entity in mainland China responsible for product recalls. This is a non-negotiable prerequisite for continued market access. Platforms like Tmall Global and Douyin are now required to enforce this, meaning they can suspend operations for any brand that has not designated a compliant recall entity. This closes a long-standing gap where overseas brands had no clear, legally accountable mechanism for managing product safety events in China.

Why are platforms like Tmall Global and Douyin becoming stricter with their merchants?

Platforms are becoming stricter because new laws hold them jointly liable with merchants for non-compliant products or false claims that harm Chinese consumers. This increased liability exposure gives platforms a strong financial incentive to proactively police their merchant base. They are tightening their review processes for product listings, requesting more documentation (like certificates of analysis and safety substantiation), and acting faster to delist non-compliant products to avoid facing massive penalties and business suspensions themselves.

Who is legally responsible if a live-streamer makes an unapproved health claim about my product?

Under the new full-chain liability model, legal responsibility can extend to the brand owner, the live-streamer, the MCN agency, and the platform simultaneously. China's regulations are designed to hold everyone involved in bringing a claim to a consumer accountable. This means a brand cannot simply blame an off-script streamer. Brands must now implement formal review processes for all live-stream content and update contracts with agencies and KOLs to include clear liability clauses for compliance breaches.

How can my brand verify if our marketing claims are compliant for the Chinese market?

The first step is to confirm your product's official regulatory classification in China, as this determines which claims are legally permissible. A claim that is perfectly legal for an ordinary food in the US or Europe may be an illegal disease-prevention claim in China. You must work with a domestic partner or specialist consultant to classify each product as either an ordinary food, a filing-track health food, or a registration-track "blue hat" health food. All marketing assets—from product pages to social media captions—must then be audited against the specific rules for that classification.

My brand works with a Tmall Partner (TP). Does this cover the new product recall requirement?

Not necessarily. You must formally confirm in a legally binding agreement that your TP is willing and equipped to act as your designated recall entity. An informal arrangement is no longer sufficient. The responsibility for recalls must be explicitly documented. You should immediately assess your agreement with your TP. If they cannot or will not serve this formal role, you must appoint another compliant domestic entity as a prerequisite for continued selling on the platform.

With all these new rules, is CBEC still a good way to enter the Chinese market?

Yes, CBEC remains a highly viable and commercially significant channel, but the era of "lighter-touch" compliance is over. The opportunity in China is unchanged, but the cost of entry now includes a higher level of regulatory rigour, similar to what is expected for the domestic market. Brands that treat compliance as a core business function—auditing claims, formalizing partnerships, and meeting structural requirements like the recall entity—will be well-positioned for sustainable success.